IMU (ASX) Ann: Imugene to present at 2024 Cholangiocarcinoma Conference

Originally posted by Odds&Evens: ↑

As of 14 July 2018, listed entities have been required to identify whether an announcement is "market sensitive" at the point of E-Lodgment on ASX online. Although ASX will still make the final determination before releasing the announcement, this requirement reinforces the need for listed entities to be cognisant of what constitutes "market sensitive". A company has an ASX liaison so if there is doubt they will interact with them.

An additional check-box was included on the E-Lodgment form for ASX announcements made via ASX's online company announcement platform, which requires listed entities to identify whether or not the announcement is "market sensitive". Previously ASX was responsible for determining whether an announcement was "market sensitive" before releasing it.

The changes were designed to improve the time taken to process and release announcements on ASX.

What announcements are "market sensitive"?

Under Listing Rule 3.1, the information in an announcement is considered market sensitive if "a reasonable person would expect the information to have a material effect on the price or value of the entity's securities". Section 677 of the Corporations Act provides further that this test is deemed to be met "if the information would, or would be likely to, influence persons who commonly invest in securities in deciding whether to acquire or dispose of the securities".

ASX advised that some announcements will automatically default to "market sensitive" and this cannot be altered by the listed entity. These include specific announcements in relation to takeovers, periodic reports such as half yearly and full year reports and mining/exploration quarterly reports.

As a result it would seem that almost all ASX announcements (apart from those more general procedural announcement, such as appointment of a new Company Secretary) will be marked as "market sensitive".

While listed entities are therefore responsible for identifying announcements as "market sensitive", the ASX will still have the ultimate responsibility of classifying the announcements. Where the ASX has classified the announcement differently to the listed entity (ie. it has determined that an announcement should have been marked as "market sensitive") no penalties or fines are imposed on the listed entity.

From a practical perspective, the process undertaken by a listed entity in determining to make an announcement did not change, as the rules with respect to "continuous disclosure" have not changed, rather this is a change to the lodgment process. Listed entities merely need to include an additional step in their announcement approval process by which it is determined whether or not to mark an announcement as "market sensitive" or not. Generally, announcements by their very nature, will almost always be "market sensitive", otherwise perhaps an entity should consider why they are making the announcement at all.

Thought this might help.

Expand

Another ps announcement resulting in a price decline. With IMU you can bet your house on it.

No.	Vol.	Price($)
40	3911198	5.4¢

No.

Vol.

Price($)

3911198

5.4¢

Price($)	Vol.	No.
5.5¢	884741	42

Price($)

Vol.

No.

5.5¢

884741

No.	Vol.	Price($)
38	3909186	0.054
25	3513273	0.053
21	1797266	0.052
18	1595967	0.051
62	5210129	0.050

No.

Vol.

Price($)

3909186

0.054

3513273

0.053

1797266

0.052

1595967

0.051

5210129

0.050

Price($)	Vol.	No.
0.055	827814	41
0.056	792145	14
0.057	1181254	9
0.058	866587	8
0.059	630440	6

Price($)

Vol.

No.

0.055

827814

0.056

792145

0.057

1181254

0.058

866587

0.059

630440

(20min delay)
Last 5.4¢		Change -0.002(3.57%)		Mkt cap ! $400.5M

Open	High	Low	Value	Volume
5.5¢	5.6¢	5.4¢	$628.8K	11.46M

Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-98

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Geochemical work at Newington picks up gold and copper anomalies for Midas

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-98

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Geochemical work at Newington picks up gold and copper anomalies for Midas

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News